Blood clusterin levels, rs9331888 polymorphism, and the risk of Alzheimer's disease

J Alzheimers Dis. 2012;29(3):515-9. doi: 10.3233/JAD-2011-111844.

Abstract

Variants in the clusterin gene have been associated with Alzheimer's disease (AD) through replicated genome-wide studies, but the underlying mechanisms remain unknown. In this study the association of the AD clusterin common risk polymorphism rs9331888 with blood clusterin levels was tested in 104 AD subjects and 104 healthy controls. Blood clusterin levels were significantly elevated in AD patients (p < 0.05). The rs9331888 AD-risk variant was associated with low clusterin mRNA and protein levels in an allele-dose dependent manner in both groups (p < 0.001). This study indicates that the rs9331888 AD-risk variant is associated with low blood clusterin levels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / blood*
  • Alzheimer Disease / genetics*
  • Analysis of Variance
  • Clusterin / blood*
  • Clusterin / genetics*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Genetic Predisposition to Disease / genetics*
  • Genome-Wide Association Study
  • Humans
  • Male
  • Polymorphism, Single Nucleotide / genetics*
  • Psychiatric Status Rating Scales
  • RNA, Messenger / metabolism
  • Risk Factors

Substances

  • Clusterin
  • RNA, Messenger